Lopinavir/ritonavir (ABT-378/r)

Author： Qazi Nadeem A   Pozniak Anton L   Morlese John F  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.3, 2002-03, pp. : 315-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

By Kumar Gondi N.   Jayanti Venkata K.   Johnson Marianne K.   Uchic John   Thomas Samuel   Lee Ronald D.   Grabowski Brian A.   Sham Hing L.   Kempf Dale J.   Denissen Jon F.   Marsh Kennan C.   Sun Eugene   Roberts Stanley A.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1622-1630

Springer Publishing Company

Access to resources Recommend Favorite

Lopinavir/ritonavir: Alopecia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1172, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Darunavir + ritonavir superior to lopinavir/ritonavir for HIV infection

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Atazanavir/ritonavir lays siege to lopinavir/ritonavir in the CASTLE

By  

Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Lopinavir/ritonavir: Xanthomatosis: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1011, 2004-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite